Carbonyl stress and a combination of astaxanthin/vitamin C induce biochemical changes in human neutrophils

Toxicology in Vitro

Volumn 26, Issue 7, 2012, Pages 1181-1190

  Guerra, B A ^a   Bolin, A P ^a   Otton, R ^a  

^a UNIVERSIDADE CRUZEIRO DO SUL   (Brazil)

Author keywords

Antioxidant; Carotenoid; Free radical; Glycation; High glucose; Leukocyte; Methylglyoxal

Indexed keywords

ASCORBIC ACID; ASTAXANTHIN; CARBONYL DERIVATIVE; CATALASE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HYPOCHLOROUS ACID; INTERLEUKIN 1BETA; INTERLEUKIN 6; METHYLGLYOXAL; MYELOPEROXIDASE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM MOBILIZATION; CALCIUM TRANSPORT; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DETERMINATION; DRUG EFFICACY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; MALE; NEUTROPHIL; OXIDATIVE STRESS; PHAGOCYTOSIS; PROTEIN EXPRESSION;

ANTIOXIDANTS; ASCORBIC ACID; CATALASE; CELL MEMBRANE; CELL SURVIVAL; CELLS, CULTURED; DRUG COMBINATIONS; FEMALE; FIBRINOLYTIC AGENTS; GLUCOSE; GLUCOSEPHOSPHATE DEHYDROGENASE; HUMANS; INTERLEUKIN-6; MALE; NEUTROPHILS; OXIDATIVE STRESS; PEROXIDASE; PHAGOCYTOSIS; PROTEIN CARBONYLATION; PYRUVALDEHYDE; REACTIVE OXYGEN SPECIES; SUPEROXIDE DISMUTASE; XANTHOPHYLLS; YOUNG ADULT;

EID: 84866017779     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2012.06.010     Document Type: Article

References (79)

1. Aebi H. Catalase in vitro. Methods Enzymol. 1984, 105:121-126.
2. Bolin A.P., Macedo R.C., Marin D.P., Barros M.P., Otton R. Astaxanthin prevents in vitro auto-oxidative injury in human lymphocytes. Cell Biol. Toxicol. 2010, 26:457-467.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
4. Brandt R., Keston A.S. Synthesis of diacetyldichlorofluorescin: a stable reagent for fluorometric analysis. Anal. Biochem. 1965, 11:6-9.
5. Brownlee M. Advanced protein glycosylation in diabetes and aging. Annu. Rev. Med. 1995, 46:223-234.
6. Campoio T.R., Oliveira F.A., Otton R. Oxidative stress in human lymphocytes treated with fatty acid mixture: role of carotenoid astaxanthin. Toxicol. in Vitro 2011, 25:1448-1456.
7. Carlberg I., Mannervik B. Glutathione reductase. Methods Enzymol. 1985, 113:484-490.
8. Chang T., Wang R., Wu L. Methylglyoxal-induced nitric oxide and peroxynitrite production in vascular smooth muscle cells. Free Radic. Biol. Med. 2005, 38:286-293.
9. Chew B.P., Park J.S., Wong M.W., Wong T.S. A comparison of the anticancer activities of dietary beta-carotene, canthaxanthin and astaxanthin in mice in vivo. Anticancer Res. 1999, 19:1849-1853.
10. Costa Rosa, L.F., Curi, R., Murphy, C., Newsholme, P., 1995. Effect of adrenaline and phorbol myristate acetate or bacterial lipopolysaccharide on stimulation of pathways of macrophage glucose, glutamine and O2 metabolism. Evidence for cyclic AMP-dependent protein kinase mediated inhibition of glucose-6-phosphate dehydrogenase and activation of NADP+-dependent 'malic' enzyme. Biochem. J. 310 (Pt 2), 709-714.
11. Crow J.P. Dichlorodihydrofluorescein and dihydrorhodamine 123 are sensitive indicators of peroxynitrite in vitro: implications for intracellular measurement of reactive nitrogen and oxygen species. Nitric Oxide 1997, 1:145-157.
12. Desai K., Wu L. Methylglyoxal and advanced glycation endproducts: new therapeutic horizons?. Recent Pat Cardiovasc Drug Discov 2007, 2:89-99.
13. Desai K.M., Chang T., Wang H., Banigesh A., Dhar A., Liu J., Untereiner A., Wu L. Oxidative stress and aging: is methylglyoxal the hidden enemy?. Can. J. Physiol. Pharmacol. 2010, 88:273-284.
14. Dhar A., Desai K., Kazachmov M., Yu P., Wu L. Methylglyoxal production in vascular smooth muscle cells from different metabolic precursors. Metabolism 2008, 57:1211-1220.
15. Ding A.H., Nathan C.F., Stuehr D.J. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 1988, 141:2407-2412.
16. Dutra F., Ciriolo M.R., Calabrese L., Bechara E.J. Aminoacetone induces oxidative modification to human plasma ceruloplasmin. Chem. Res. Toxicol. 2005, 18:755-760.
17. Dypbukt J.M., Bishop C., Brooks W.M., Thong B., Eriksson H., Kettle A.J. A sensitive and selective assay for chloramine production by myeloperoxidase. Free Radic. Biol. Med. 2005, 39:1468-1477.
18. Ewing J.F., Janero D.R. Microplate superoxide dismutase assay employing a nonenzymatic superoxide generator. Anal. Biochem. 1995, 232:243-248.
19. Fassett R.G., Coombes J.S. Astaxanthin: a potential therapeutic agent in cardiovascular disease. Mar Drugs 2011, 9:447-465.
20. Fialkow L., Wang Y., Downey G.P. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic. Biol. Med. 2007, 42:153-164.
21. Fleming S.T., Love M.M., Bennett K. Diabetes and cancer screening rates among Appalachian and non-Appalachian residents of Kentucky. J. Am. Board Fam. Med. 2011, 24:682-692.
22. Fukuzawa K., Inokami Y., Tokumura A., Terao J., Suzuki A. Rate constants for quenching singlet oxygen and activities for inhibiting lipid peroxidation of carotenoids and alpha-tocopherol in liposomes. Lipids 1998, 33:751-756.
23. Gebska A., Olszanecki R., Korbut R. Endotoxaemia in rats: role of leukocyte sequestration in rapid pulmonary nitric oxide synthase-2 expression. J. Physiol. Pharmacol. 2005, 56:299-311.
24. Goldschmidt M.C. Reduced bactericidal activity in neutrophils from scorbutic animals and the effect of ascorbic acid on these target bacteria in vivo and in vitro. Am. J. Clin. Nutr. 1991, 54:1214S-1220S.
25. Grynkiewicz G., Poenie M., Tsien R.Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985, 260:3440-3450.
26. Guaiquil V.H., Vera J.C., Golde D.W. Mechanism of vitamin C inhibition of cell death induced by oxidative stress in glutathione-depleted HL-60 cells. J. Biol. Chem. 2001, 276:40955-40961.
27. Guerra B.A., Otton R. Impact of the carotenoid astaxanthin on phagocytic capacity and ROS/RNS production of human neutrophils treated with free fatty acids and high glucose. Int. Immunopharmacol. 2011, 11:2220-2226.
28. Gustapane M., Cardillo M.T., Biasillo G., Biasucci L.M. Myeloperoxidase as possible diagnostic and prognostic marker of acute coronary syndrome. Recenti Prog. Med. 2011, 102:447-450.
29. Hampton M.B., Kettle A.J., Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998, 92:3007-3017.
30. Hatanaka E., Levada-Pires A.C., Pithon-Curi T.C., Curi R. Systematic study on ROS production induced by oleic, linoleic, and gamma-linolenic acids in human and rat neutrophils. Free Radic. Biol. Med. 2006, 41:1124-1132.
31. Hussein G., Sankawa U., Goto H., Matsumoto K., Watanabe H. Astaxanthin, a carotenoid with potential in human health and nutrition. J. Nat. Prod. 2006, 69:443-449.
32. Juurlink B.H. Management of oxidative stress in the CNS: the many roles of glutathione. Neurotox. Res. 1999, 1:119-140.
33. Jyonouchi H., Sun S., Iijima K., Gross M.D. Antitumor activity of astaxanthin and its mode of action. Nutr. Cancer 2000, 36:59-65.
34. Kalapos M.P. Methylglyoxal in living organisms: chemistry, biochemistry, toxicology and biological implications. Toxicol. Lett. 1999, 110:145-175.
35. Kettle A.J., Gedye C.A., Winterbourn C.C. Mechanism of inactivation of myeloperoxidase by 4-aminobenzoic acid hydrazide. Biochem. J. 1997, 321(Pt 2):503-508.
36. Kidd P. Astaxanthin, cell membrane nutrient with diverse clinical benefits and anti-aging potential. Altern. Med. Rev. 2011, 16:355-364.
37. Kikuchi S., Shinpo K., Moriwaka F., Makita Z., Miyata T., Tashiro K. Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases. J. Neurosci. Res. 1999, 57:280-289.
38. Kishimoto Y., Tani M., Uto-Kondo H., Iizuka M., Saita E., Sone H., Kurata H., Kondo K. Astaxanthin suppresses scavenger receptor expression and matrix metalloproteinase activity in macrophages. Eur. J. Nutr. 2010, 49:119-126.
39. Kleinert H., Pautz A., Linker K., Schwarz P.M. Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 2004, 500:255-266.
40. Kuijpers T.W., van den Berg J.M., Tool A.T., Roos D. The impact of platelet-activating factor (PAF)-like mediators on the functional activity of neutrophils: anti-inflammatory effects of human PAF-acetylhydrolase. Clin. Exp. Immunol. 2001, 123:412-420.
41. Lecube A., Pachon G., Petriz J., Hernandez C., Simo R. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One 2011, 6:e23366.
42. Lee W.L., Harrison R.E., Grinstein S. Phagocytosis by neutrophils. Microbes Infect. 2003, 5:1299-1306.
43. Leoncini G., Poggi M. Effects of methylglyoxal on platelet hydrogen peroxide accumulation, aggregation and release reaction. Cell Biochem. Funct. 1996, 14:89-95.
44. Macedo R.C., Bolin A.P., Marin D.P., Otton R. Astaxanthin addition improves human neutrophils function: in vitro study. Eur. J. Nutr. 2010, 49:447-457.
45. Maeng H.G., Lim H., Jeong Y.J., Woo A., Kang J.S., Lee W.J., Hwang Y.I. Vitamin C enters mouse T cells as dehydroascorbic acid in vitro and does not recapitulate in vivo vitamin C effects. Immunobiology 2009, 214:311-320.
46. Mannervik B. Glutathione peroxidase. Methods Enzymol. 1985, 113:490-495.
47. Marin D.P., Bolin A.P., Macedo Rde C., Sampaio S.C., Otton R. ROS production in neutrophils from alloxan-induced diabetic rats treated in vivo with astaxanthin. Int. Immunopharmacol. 2011, 11:103-109.
48. Mattei R., Polotow T.G., Vardaris C.V., Guerra B.A., Leite J.R., Otton R., Barros M.P. Astaxanthin limits fish oil-related oxidative insult in the anterior forebrain of Wistar rats: putative anxiolytic effects?. Pharmacol. Biochem. Behav. 2011, 99:349-355.
49. Meister A. Glutathione metabolism and its selective modification. J. Biol. Chem. 1988, 263:17205-17208.
50. Myzak M.C., Carr A.C. Myeloperoxidase-dependent caspase-3 activation and apoptosis in HL-60 cells: protection by the antioxidants ascorbate and (dihydro)lipoic acid. Redox Rep. 2002, 7:47-53.
51. Naguib Y.M. Antioxidant activities of astaxanthin and related carotenoids. J. Agric. Food Chem. 2000, 48:1150-1154.
52. Otton R., da Silva D.O., Campoio T.R., Silveira L.R., de Souza M.O., Hatanaka E., Curi R. Non-esterified fatty acids and human lymphocyte death: a mechanism that involves calcium release and oxidative stress. J. Endocrinol. 2007, 195:133-143.
53. Otton R., Marin D.P., Bolin A.P., Santos Rde C., Polotow T.G., Sampaio S.C., de Barros M.P. Astaxanthin ameliorates the redox imbalance in lymphocytes of experimental diabetic rats. Chem. Biol. Interact. 2010, 186:306-315.
54. Otton, R., Marin, D.P., Bolin, A.P., de Cassia Santos Macedo, R., Campoio, T.R., Fineto, C., Jr., Guerra, B.A., Leite, J.R., Barros, M.P., Mattei, R., 2011. Combined fish oil and astaxanthin supplementation modulates rat lymphocyte function. Eur. J. Nutr. epub ahead of print.
55. Paget C., Lecomte M., Ruggiero D., Wiernsperger N., Lagarde M. Modification of enzymatic antioxidants in retinal microvascular cells by glucose or advanced glycation end products. Free Radic. Biol. Med. 1998, 25:121-129.
56. Park Y.S., Koh Y.H., Takahashi M., Miyamoto Y., Suzuki K., Dohmae N., Takio K., Honke K., Taniguchi N. Identification of the binding site of methylglyoxal on glutathione peroxidase: methylglyoxal inhibits glutathione peroxidase activity via binding to glutathione binding sites Arg 184 and 185. Free Radic. Res. 2003, 37:205-211.
57. Pick E., Mizel D. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods 1981, 46:211-226.
58. Price C.L., Hassi H.O., English N.R., Blakemore A.I., Stagg A.J., Knight S.C. Methylglyoxal modulates immune responses: relevance to diabetes. J. Cell Mol. Med. 2010, 14:1806-1815.
59. Rahman I., Kode A., Biswas S.K. Assay for quantitative determination of glutathione and glutathione disulfide levels using enzymatic recycling method. Nat. Protoc. 2006, 1:3159-3165.
60. Sampaio S.C., Sousa-e-Silva M.C., Borelli P., Curi R., Cury Y. Crotalus durissus terrificus snake venom regulates macrophage metabolism and function. J. Leukoc. Biol. 2001, 70:551-558.
61. Savenkova M.L., Mueller D.M., Heinecke J.W. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J. Biol. Chem. 1994, 269:20394-20400.
62. Scapini P., Lapinet-Vera J.A., Gasperini S., Calzetti F., Bazzoni F., Cassatella M.A. The neutrophil as a cellular source of chemokines. Immunol. Rev. 2000, 177:195-203.
63. Schmidt A.M., Hasu M., Popov D., Zhang J.H., Chen J., Yan S.D., Brett J., Cao R., Kuwabara K., Costache G., et al. Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins. Proc. Natl. Acad. Sci. USA 1994, 91:8807-8811.
64. Sheppard F.R., Kelher M.R., Moore E.E., McLaughlin N.J., Banerjee A., Silliman C.C. Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation. J. Leukoc. Biol. 2005, 78:1025-1042.
65. Shinpo K., Kikuchi S., Sasaki H., Ogata A., Moriwaka F., Tashiro K. Selective vulnerability of spinal motor neurons to reactive dicarbonyl compounds, intermediate products of glycation, in vitro: implication of inefficient glutathione system in spinal motor neurons. Brain Res. 2000, 861:151-159.
66. Sies H., Stahl W. Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am. J. Clin. Nutr. 1995, 62:1315S-1321S.
67. Tajima K., Hosokawa K., Yoshida Y., Dantes A., Sasson R., Kotsuji F., Amsterdam A. Establishment of FSH-responsive cell lines by transfection of pre-ovulatory human granulosa cells with mutated p53 (p53val135) and Ha-ras genes. Mol. Hum. Reprod. 2002, 8:48-57.
68. Takedo A., Yasuda T., Miyata T., Mizuno K., Li M., Yoneyama S., Horie K., Maeda K., Sobue G. Immunohistochemical study of advanced glycation end products in aging and Alzheimer's disease brain. Neurosci. Lett. 1996, 221:17-20.
69. Thornalley P.J. Measurement of protein glycation, glycated peptides, and glycation free adducts. Perit. Dial. Int. 2005, 25:522-533.
70. Turk Z. Glycotoxines, carbonyl stress and relevance to diabetes and its complications. Physiol. Res. 2010, 59:147-156.
71. Vissers M.C., Wilkie R.P. Ascorbate deficiency results in impaired neutrophil apoptosis and clearance and is associated with up-regulation of hypoxia-inducible factor 1alpha. J. Leukoc. Biol. 2007, 81:1236-1244.
72. Wang Y., Russo T.A., Kwon O., Chanock S., Rumsey S.C., Levine M. Ascorbate recycling in human neutrophils: induction by bacteria. Proc Natl Acad Sci U S A 1997, 94:13816-13819.
73. Wang X., Desai K., Chang T., Wu L. Vascular methylglyoxal metabolism and the development of hypertension. J. Hypertens. 2005, 23:1565-1573.
74. Wang H., Meng Q.H., Gordon J.R., Khandwala H., Wu L. Proinflammatory and proapoptotic effects of methylglyoxal on neutrophils from patients with type 2 diabetes mellitus. Clin. Biochem. 2007, 40:1232-1239.
75. Wang H., Liu J., Wu L. Methylglyoxal-induced mitochondrial dysfunction in vascular smooth muscle cells. Biochem. Pharmacol. 2009, 77:1709-1716.
76. Ward R.A., McLeish K.R. Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure?. Nephrol. Dial. Transplant. 2004, 19:1702-1707.
77. Winterbourn C.C., Kettle A.J. Reactions of superoxide with myeloperoxidase and its products. Jpn. J. Infect. Dis. 2004, 57:S31-33.
78. Wu L., Juurlink B.H. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension 2002, 39:809-814.
79. Yuan J.P., Peng J., Yin K., Wang J.H. Potential health-promoting effects of astaxanthin: a high-value carotenoid mostly from microalgae. Mol. Nutr. Food Res. 2011, 55:150-165.